Ignite Creation Date:
2024-05-06 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05063136
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2021-09-13
Brief Title:
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HRHER2- Primary Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Organization Data
Organization:
Henan Cancer Hospital
Class:
OTHER_GOV
Study ID:
HELEN-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henan Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Zhenzhen Liu
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Henan Cancer Hospital
Old Name:
None
Old Organization:
None